Showing 771-780 of 3260 results for "".
Practical Dermatology® Magazine Recognizes Top Content
https://practicaldermatology.com/topics/practice-management/practical-dermatology-magazine-recognizes-top-content/20563/Here's the most popular content from Practical Dermatology® brands online.The Best Skincare Products for Eczema, According to Your Peers
https://practicaldermatology.com/topics/atopic-dermatitis/the-best-skincare-products-for-eczema-according-to-your-peers/23747/Conversations in Acne, Part 1
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-1/19867/As treatment options for acne expand, clinicians consider the potential to combine topical therapies or pair topicals with systemics, all while adhering to guidelines for care and prescribing antibiotics responsibly. In the first episode of this three-part series, host Neal Bhatia, MD speaks with HiWhy Consider Lasers?
https://practicaldermatology.com/topics/practice-management/why-consider-lasers/18863/Should younger dermatologists add devices to their practice? Laser expert Eric Bernstein, MD talks about the decision to embrace technology and explains how it can mold the future of those who have a passion for lasers and other energy-based devices. Watch other PD Asks videos with Eric BernsteinI knew I wanted to become a dermatologist when...
https://practicaldermatology.com/topics/practice-management/i-knew-i-wanted-to-become-a-dermatologist-when---opefutim/18682/PD Asks: When Yolanda Lenzy, MD was about 13 years old she visited the office of Dr. Lynn McKinley Grant in Washington, DC. It was her first experience with an African American physician, and Dr. Lenzy describes how Dr. McKinley Grant inspired and supported her aspirations. Watch other responses toDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)Conversations in Acne, Part 2
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-2/19871/From isotretinoin to antibiotics—including next generation tetracyclines—the experts talk about key considerations for optimal outcomes, including the impact of diet. They also discuss management of trunk acne and strategies to reduce the risk for bacterial resistance. Host Neal Bhatia, MD leads theDermWireTV: AIRE SkinStore, Telehealth Cuts Consult Wait Times, Social Media and Realistic Expectations
https://practicaldermatology.com/topics/practice-management/dermwiretv-aire-skinstore-telehealth-cuts-consult-wait-times-social-media-and-realistic-expectations/19874/Launching with seven skincare brands, AIRE SkinStore allows dermatologists across the country to curate product recommendations, while providing discounts for their patients, says creator Dhaval Bhanusali, MD. Use of store-and-forward telemedicine can cut wait times for dermatology consults from 84Burnout: Is Personal Happiness the Answer?
https://practicaldermatology.com/programs/practical-dermatology/burnout-is-personal-happiness-the-answer/18191/Physician burnout remains a conversation, and the pandemic dramatically changed the landscape for dermatologists—for better and for worse. Omaha, NE-based Joel Schlessinger, MD, who serves as Chief Cosmetic Surgery Editor of Practical Dermatology® speaks with Las Vegas-based dermatologist H.L. GreenPD Asks: The Future of Cosmetic Surgery
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pd-asks-the-future-of-cosmetic-surgery/18680/PD Asks Joel Schlessinger, MD about the future of cosmetic dermatology. Watch Dr. Schlesinger discuss his views about how the speciality has evolved and grown with solid scientific research about treatments including fillers and toxins. He also discusses his meeting, Cosmetic Surgery Forum. Watch o